Environmental, Social And Governance Report

Overview

The report presents Hansoh Pharma's 2025 ESG governance, climate strategy, environmental performance, talent development and access-to-healthcare activities. It describes Board-level ESG oversight and reports 109,662.60 tCO2e of Scope I and II emissions, alongside a 40% 2030 intensity-reduction target from a 2021 base year. The Group reports 9,347 employees, 39.01 average training hours per employee and a 42.9% share of women on the Board. The report also includes a reproduced independent assurance statement from China Quality Certification Centre using AA1000 v3, Type 2, Moderate Assurance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview